Recordati Industria Chimica e Farmaceutica S.p.A. (RCDTF)

Market Cap	12.98B
Revenue (ttm)	2.61B
Net Income (ttm)	451.74M
Shares Out	n/a
EPS (ttm)	2.16
PE Ratio	28.74
Forward PE	16.42
Dividend	1.38 (2.11%)
Ex-Dividend Date	May 19, 2025

Volume	2
Average Volume	15
Open	51.60
Previous Close	65.44
Day's Range	51.60 - 65.44
52-Week Range	49.00 - 65.44
Beta	0.52
RSI	97.78
Earnings Date	Jul 29, 2025

About RCDTF

Recordati Industria Chimica e Farmaceutica S.p.A., together with its subsidiaries, researches, develops, produces, and sells pharmaceuticals in Italy, the United States, Spain, France, Germany, Russia, Ukraine, Turkey, Portugal, North Africa, and internationally. It operates through Specialty and Primary Care; and Rare Diseases segments. The company develops REC 0545 for acute decompensation in maple syrup urine diseases; Isturia for endogenous Cushing’s syndrome; Cystadrops for corneal cystine crystal deposits; Carbaglu for hyperammonemia due ...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1926
• Employees: 4,583
• Stock Exchange: OTCMKTS
• Ticker Symbol: RCDTF

Financial Performance

In 2024, RCDTF's revenue was 2.34 billion, an increase of 12.45% compared to the previous year's 2.08 billion. Earnings were 416.51 million, an increase of 7.01%.

Financial numbers in EUR